01 November 2007

Religare IPO oversubscribed 156.44 times on closing, other stories

Initial public offering of Religare Enterprises (Q, N,C,F)* (REL), a financial services company, received overwhelming response from investors. It was oversubscribed 156.44 times on closing day till 6 pm. It received 1,185,175,915 bids as against issue size of 7,576,102 shares. A total of 171,621,205 bids were received at the cut off price. The price band was fixed between Rs 160 to Rs 185 a share. REL is promoted by the promoters of Ranbaxy Laboratories and the issue is graded by ICRA with an IPO Grade 3 on a 5 point scale.

The equity shares of the company, offered through this IPO, are proposed to be listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). REL is a holding company of 11 subsidiaries, which are engaged in a wide range of financial products and services targeted at the retail, high networth individuals and the corporate and institutional clients. Along with its various subsidiaries, it offers a wide range of services ranging from equities,
commodities, insurance broking, to wealth advisory, portfolio management services, personal finance services, investment banking and institutional broking services.

It has divided its product and service offering under three broad client interface categories i.e. retail spectrum, wealth spectrum and institutional spectrum

and other stories from Myiris.Com

Barak Valley IPO oversubscribed 28.53 times on closing

Gammon India net down 34.49% for Sep`07 qtr

Mundra Port IPO seems to be attractive

Mundra Port IPO oversubscribed 4.67 times on day one

Consolidated Construction bags orders worth Rs 1275.3mn

Suzlon to export to 40 countries in five years

IFC eyes Rs 1433.9 mn worth stake in Karnataka Bank

Titan Eye+ to open 250 stores across India



We thank (will be grateful to) the owners of the above articles/sites/sources/Govts www.myiris.com allowing/referring this. We are just providing the link/information of business updates from the leading sources for the benefit of readers.

No comments: